Cymabay Therapeutics Inc (NASDAQ:CBAY)

2.77
Delayed Data
As of 4:00pm ET
 -0.15 / -5.14%
Today’s Change
2.77
Today|||52-Week Range
6.56
-18.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-18.6M-19.4M-23.1M-24.0M
 
 
 
 
 
Depreciation14.0K66.0K138.0K140.0K
 
 
 
 
 
Total Other Cash Flow-399.0K1.0M1.8M1.5M
 
 
 
 
 
Funds From Operations-18.9M-18.3M-21.1M-22.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.9M1.3M1.3M1.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-16.1M-19.6M-22.4M-24.3M
 
 
 
 
 
 
InvestingIncrease In Investments-63.5M-27.0M-90.9M-130.4M
 
 
 
 
 
Decrease In Investments75.1M54.2M82.0M57.4M
 
 
 
 
 
Capital Expenditures-14.0K-469.0K-178.0K-91.0K
 
 
 
 
 
Net Cash Flow Investing11.6M26.8M-9.0M-73.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.5M24.0K108.0M-167.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing1.5M24.0K108.0M-167.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-2.9M7.2M76.6M-97.5M